Results 11 to 20 of about 11,658 (260)

Association between non-scarring alopecia and hypothyroidism: a bidirectional two-sample Mendelian randomization study [PDF]

Frontiers in Endocrinology
BackgroundNon-scarring alopecia is typically represented by two main types: alopecia areata (AA) and androgenetic alopecia (AGA). While previous observational studies have indicated a link between non-scarring alopecia and hypothyroidism, the precise ...
Jiankang Yang, Jiankang Yang, Zhenlai Zhu, Chen Zhang, Yanyang Guo, Gang Wang, Meng Fu   +6 more
doaj   +2 more sources

Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib [PDF]

Frontiers in Immunology, 2021
The Janus kinases (JAKs) are intracellular tyrosine kinases involved in a broad variety of inflammatory cascades participating in the pathogenesis of systemic lupus erythematosus (SLE).
Yu-Lan Chen, Li-Xiong Liu, Qin Huang, Xue-Ying Li, Xiao-Ping Hong, Dong-Zhou Liu   +5 more
doaj   +2 more sources

Research progress in the treatment of non-scarring alopecia: mechanism and treatment [PDF]

Frontiers in Pharmacology
IntroductionNon-scarring alopecia, encompassing androgenetic alopecia (AGA), alopecia areata (AA), and telogen effluvium (TE), is a common skin condition that significantly impacts both the physical and psychological wellbeing of affected individuals ...
Rui-Xian Guo, Yong-Kang Zhao, Ke-Jian Hu, Kun-Mu Jia, Wei Shi, Yan-Xiao Yi, Hai-Ying Gong, Jia-Bo Wang, Jia-Bo Wang, Yuan Gao   +9 more
doaj   +2 more sources

Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect [PDF]

Dermatopathology
A 74-year-old woman in good general health presented with a 5-year history of progressive hair loss over several years, interpreted as female androgenetic alopecia (AGA), and was treated with topical 5% Minoxidil without improvement.
Carlo Francesco Tomasini, Giacomo Fiandrino, Emanuele Mario Favale, Francesca Antoci, Stefania Barruscotti   +4 more
doaj   +2 more sources

Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis. [PDF]

J Psoriasis Psoriatic Arthritis, 2023
Baniel A, Peled A, Samuelov L, Zemser V, Gat A, Dodiuk-Gad RP, Ziv M, Azzam W, Zittan E, Matz H, Sprecher E, Pavlovsky M.   +11 more
europepmc   +3 more sources

Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction. [PDF]

Skin Appendage Disord
Brinks A, Kearney C, Needle C, Pulavarty A, Shapiro J, Lo Sicco KI.   +5 more
europepmc   +3 more sources

Scarring versus Non-Scarring Alopecia: An Interobserver Histopathological Reproducibility Study. [PDF]

Skin Appendage Disord, 2023
Botega AADR, Amorim CV, Teixeira F, Borges Figueira de Mello CD, Stelini RF, Velho PENF, Cintra ML.   +6 more
europepmc   +3 more sources

Clinico-Epidemiology and Histopathologic Spectrum of Primary Scarring Alopecia: A Cross-Sectional Study.

Indian J Dermatol, 2022
Sardar S, Sarkar S, Podder I, Banerjee G.   +3 more
europepmc   +2 more sources

Alopecia areata-like patchy non-scarring alopecia as an initial presentation of systemic lupus erythematosus. [PDF]

Rheumatol Adv Pract, 2023
Ueda Y, Mizuta T, Murata S, Yokogawa N.
europepmc   +3 more sources

Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Hair loss disorders impact quality of life (QoL) far beyond cosmetic issues, with previous studies showing mild to moderate impairment. This study aimed to assess QoL impairment in hair loss patients, comparing scarring and non‐scarring alopecia, and to analyze possibly related influencing factors.
Agathe Franz, Andria Constantinou, G. Engelhardt, Rashmi Singh, Doris Wilborn, Kathrin Hillmann, Sein Schmidt, Ulrike Blume‐Peytavi   +7 more
openalex   +2 more sources